Measurement of Free Polysaccharide in Tetanus Toxoid-Conjugate Vaccine Using Antibody/Ammonium Sulfate Precipitation |
Yoo, Tae-Hyeon
(Green Cross Vaccine Corporation)
Kim, Hyun-Sung (Green Cross Vaccine Corporation, Department of Boitechnology and Bioengineering, Inha University) Park, Sung-Sik (Green Cross Vaccine Corporation) Bang, Eun-Young (Green Cross Vaccine Corporation) Oh, Yong-K. (Green Cross Vaccine Corporation) Kim, Li-Seop (Green Cross Vaccine Corporation) Kim, Hun (Green Cross Vaccine Corporation, Department of Molecular Science and Technology) Hur, Byung-Ki (Department of Boitechnology and Bioengineering, Inha University) Ryu, Yeon-Woo (Department of Molecular Science and Technology, Ajou University) Kim, Jong-Su (Green Cross Vaccine Corporation) |
1 | Bae, C. S., K. N. Park, S. J. Ahn, S. J. Kim, and B. K. Hur. 2002. Development of a quardrivalent combined DTaP-HepB vaccine with a low toxicity and a stable HBsAg immunogenicity. J. Microbiol. Biotechnol. 12: 787-792 과학기술학회마을 |
2 |
Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates
/
|
3 |
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy
/
DOI ScienceOn |
4 |
Antibody responses to four Haemophilus influenzae type b conjugate vaccines
/
|
5 |
Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland
/
|
6 |
Responses of children immunized with the capsular polysaccharide of Haemophilus influenzae type b
/
|
7 |
A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine
/
DOI ScienceOn |
8 |
Development of a quardrivalent combined DTaP-HepB vaccine with a low toxicity and a stable HBsAg immunogenicity
/
과학기술학회마을 |
9 |
Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines
/
|
10 |
Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates
/
DOI ScienceOn |
11 |
Stability testing in Haemophilus influenzae type b conjugate vaccines
/
|
12 |
Immunization with oligosaccharide conjugate Haemophilus influenzae type b(HbOC) vaccine on a large health maintenance organization poplation: Extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group
/
|
13 |
/
|
14 |
Carbohydrates estimates
/
|
15 |
A quantitative immunochemical measure of the primary interaction between I*BSA and antibody
/
DOI ScienceOn |
16 |
/
|
17 |
Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease
/
DOI |
18 |
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b(HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group
/
DOI ScienceOn |
19 |
Quantitation of low level unconjugated polysaccharide in tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HCI
/
DOI ScienceOn |